AcquisitionJan 12, 2026Pending
🇺🇸 United States
OOneOncologyCCencora, Inc.
Healthcare › Healthcare Services
Deal valueUndisclosed
AnnouncedJan 12, 2026
ConsiderationUndisclosed
StructureNot stated
RegionNorth America
Cross-borderNo
Contingent paymentNo
Overview
Cencora, Inc. agreed to acquire the majority of the outstanding equity interests in OneOncology that it does not already own. The financing consists of a $1.5 billion term loan and a $3.0 billion 364-day term loan, which replace the $4.5 billion bridge commitments, plus a $1.0 billion increase to the revolving credit facility.
Deal rationale
The document presents the new term loan facilities as funding part of the acquisition consideration, repayment of OneOncology's existing debt, and related fees and expenses.
AI-generated from the SEC filingPendingHealthcare › Healthcare ServicesUnited StatesNorth America
Timeline
Valuation and terms
| Equity value | Undisclosed | |
|---|---|---|
| Enterprise value | Undisclosed | |
| Consideration | Undisclosed |
Advisors
Buy-side
CCitiJPJ.P. Morgan
Sell-side
None listed
Parties
Target
OOneOncology
- Headquarters
- United States
- Ticker
- —